Dexcom Inc

NASDAQ:DXCMUnited States

DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.

Contact Information

Headquarters

6340 Sequence DrSAN DIEGO, CA, United States 92121-4356

Phone

858-200-0200

Fax

302-636-5454

Executives

Chairman of the Board, President, Chief Executive Officer

Kevin Sayer

Chief Financial Officer, Executive Vice President

Jereme Sylvain

Executive Vice President, Chief Operating Officer

Jacob Leach

Chief Human Resource Officer, Executive Vice President

Sadie Stern

Executive Vice President, Chief Technology Officer

Girish Naganathan